Rafael Holdings elects N. Scott Fine as ex-officio director; Cyclo CEO departs with $852K severance

Rafael Holdings, Inc.

N. Scott Fine elected as ex-officio (non-voting) director of Rafael Holdings.
Fine resigned as CEO of Cyclo Therapeutics (subsidiary), effective July 31, 2025.
Severance payment of $852,168 in 36 semi-monthly installments plus continued equity vesting.
Board amended bylaws to authorize ex-officio directors and vice chairman officer position.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Rafael Holdings, Inc.: Adopted Fourth Amended and Restated By-Laws adding ex-officio (non-voting) directors and authorizing vice chairman position, with corresponding changes to various articles and sections (effective 2025-07-14).

Change: bylaw amendment
Effective: 2025-07-14

Exact text from the filing

On July 14, 2025, the Board of Directors of the Company adopted the Company’s Fourth Amended and Restated By-Laws, effective as of July 14, 2025, with the effect of adding ex-officio (non-voting) directors (in addition to voting directors) to the Board and authorizing the officer position of vice chairman and making corresponding changes to the following Articles and Sections: ● Article III, Sections 1, 2, 3, 4, 5, 6, 8, and 11. ● Article IV, Section 1. ● Article IX.

View on SEC.gov

Browse all governance changes →

Rafael Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-065353

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.